All posts tagged in accounting for approximately 13% or $6 billion of its total $44 billion earnings. AstraZeneca’s significant presence in China

In a significant development for the pharmaceutical giant AstraZeneca, Chinese authorities have reportedly detained five current and former employees as part of an investigation into potential breaches of data privacy